The global Topical Pain Relief market is projected to reach $13.3 billion by 2028, growing at a compound annual growth rate (CAGR) of 5.44% from 2021 to 2028. This growth is driven by various macroeconomic and microeconomic factors, including the rising prevalence of arthritis and other bone-related conditions.
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
By Therapeutic Class (Non-opioids, Opioids)
By Type (Prescription Pain Relief, Over-the-counter (OTC) Pain Relief)
By Distribution Channel(Pharmacy & Drug Store, e-Commerce, Retail & Grocery Store)
Key players
Advacare Pharma
Glaxosmithkline Plc
Johnson & Johnson
Nestlé
Novartis AG
Pfizer Inc
Reckitt Benckiser Group Plc
Sanofi
Sun Pharmaceutical Industries Ltd.
Topical Biomedics, Inc.
- Chapter 1. Executive Summary
- Chapter 2. Scope Of The Study
- 2.1. Market Definition
- 2.2. Scope Of The Study
- 2.2.1. Objectives of Report
- Chapter 3. Evolve BI Methodology
- Chapter 4. Market Insights and Trends
- 4.1. Supply/ Value Chain Analysis
- 4.2. Porter’s Five Forces Analysis
- 4.2.1. Threat Of New Entrants
- 4.2.2. Bargaining Power Of Buyers
- 4.2.3. Bargaining Power Of Suppliers
- 4.2.4. Threat Of Substitutes
- 4.2.5. Industry Rivalry
- 4.3. Impact of COVID-19 on Topical Pain Relief Market
- 4.3.1. Impact on Market Size
- 4.3.2. End User Trend, Preferences and Budget Impact
- 4.3.3. Regulatory Framework/Government Policies
- 4.3.4. Key Players Strategy to Tackle Negative Impact
- 4.3.5. Opportunity Window
- Chapter 5. Market Dynamics
- 5.1. Introduction
- 5.2. DRO Analysis
- 5.2.1. Drivers
- 5.2.2. Restraints
- 5.2.3. Opportunities
- Chapter 6. Global Topical Pain Relief Market, By Therapeutic Class
- 6.1. Introduction
- 6.2. Non-opioids
- 6.3. Opioids
- Chapter 7. Global Topical Pain Relief Market, By Type
- 7.1. Introduction
- 7.2. Prescription Pain Relief
- 7.3. Over-the-counter Pain Relief
- Chapter 8. Global Topical Pain Relief Market, By Distribution Channel
- 8.1. Introduction
- 8.2. Pharmacy & Drug Store
- 8.3. e-Commerce
- 8.4. Retail & Grocery Store
- Chapter 9. Global Topical Pain Relief Market, By Region
- 9.1. Introduction
- 9.2. North America
- 9.2.1. Introduction
- 9.2.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.2.3. Market Size and Forecast, By Country, 2020 - 2028
- 9.2.4. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.2.5. Market Size and Forecast, By Type, 2020 - 2028
- 9.2.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.2.7. US
- 9.2.7.1. Introduction
- 9.2.7.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.2.7.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.2.7.4. Market Size and Forecast, By Type, 2020 - 2028
- 9.2.7.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.2.8. Canada
- 9.2.8.1. Introduction
- 9.2.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.2.8.4. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.2.8.5. Market Size and Forecast, By Type, 2020 - 2028
- 9.2.8.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.3. Market Size and Forecast, By Country, 2020 - 2028
- 9.3.4. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.3.5. Market Size and Forecast, By Type, 2020 - 2028
- 9.3.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.3.7. Germany
- 9.3.7.1. Introduction
- 9.3.7.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.7.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.3.7.4. Market Size and Forecast, By Type, 2020 - 2028
- 9.3.7.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.3.8. France
- 9.3.8.1. Introduction
- 9.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.8.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.3.8.4. Market Size and Forecast, By Type, 2020 - 2028
- 9.3.8.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.3.9. UK
- 9.3.9.1. Introduction
- 9.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.9.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.3.9.4. Market Size and Forecast, By Type, 2020 - 2028
- 9.3.9.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.3.10. Italy
- 9.3.10.1. Introduction
- 9.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.10.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.3.10.4. Market Size and Forecast, By Type, 2020 - 2028
- 9.3.10.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.3.11. Rest Of Europe
- 9.3.11.1. Introduction
- 9.3.11.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.11.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.3.11.4. Market Size and Forecast, By Type, 2020 - 2028
- 9.3.11.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.4. Asia-Pacific
- 9.4.1. Introduction
- 9.4.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.3. Market Size and Forecast, By Country, 2020 - 2028
- 9.4.4. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.4.5. Market Size and Forecast, By Type, 2020 - 2028
- 9.4.7. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.4.8. China
- 9.4.8.1. Introduction
- 9.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.8.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.4.8.4. Market Size and Forecast, By Type, 2020 - 2028
- 9.4.8.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.4.9. India
- 9.4.9.1. Introduction
- 9.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.9.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.4.9.4. Market Size and Forecast, By Type, 2020 - 2028
- 9.4.9.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.4.10. Japan
- 9.4.10.1. Introduction
- 9.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.10.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.4.10.4. Market Size and Forecast, By Type, 2020 - 2028
- 9.4.10.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.4.11. South Korea
- 9.4.11.1. Introduction
- 9.4.11.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.11.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.4.11.4. Market Size and Forecast, By Type, 2020 - 2028
- 9.4.11.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.4.12. Rest Of Asia-Pacific
- 9.4.11.1. Introduction
- 9.4.12.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.12.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.4.12.4. Market Size and Forecast, By Type, 2020 - 2028
- 9.4.12.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.5. Rest Of The World (RoW)
- 9.5.1. Introduction
- 9.5.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.5.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.5.4. Market Size and Forecast, By Type, 2020 - 2028
- 9.5.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.5.6. Market Size and Forecast, By Region, 2020 - 2028
- 9.5.7. South America
- 9.5.7.1. Introduction
- 9.5.7.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.5.7.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.5.7.4. Market Size and Forecast, By Type, 2020 - 2028
- 9.5.7.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 9.5.8. Middle East & Africa
- 9.5.8.1. Introduction
- 9.5.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.5.8.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
- 9.5.8.4. Market Size and Forecast, By Type, 2020 - 2028
- 9.5.8.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- Chapter 10. Competitive Landscape
- 10.1. Introduction
- 10.2. Vendor Share Analysis, 2020/Key Players Positioning 2020
- Chapter 11. Company Profiles
- 11.1. Advacare Pharma
- 11.1.1. Business Overview
- 11.1.2. Financial Analysis
- 11.1.3. Product Portfolio
- 11.1.4. Recent Development and Strategies Adopted
- 11.1.5. SWOT Analysis
- 11.2. Glaxosmithkline Plc
- 11.2.1. Business Overview
- 11.2.2. Financial Analysis
- 11.2.3. Product Portfolio
- 11.2.4. Recent Development and Strategies Adopted
- 11.2.5. SWOT Analysis
- 11.3. Johnson & Johnson
- 11.3.1. Business Overview
- 11.3.2. Financial Analysis
- 11.3.3. Product Portfolio
- 11.3.4. Recent Development and Strategies Adopted
- 11.3.5. SWOT Analysis
- 11.4. Nestlé
- 11.4.1. Business Overview
- 11.4.2. Financial Analysis
- 11.4.3. Product Portfolio
- 11.4.4. Recent Development and Strategies Adopted
- 11.4.5. SWOT Analysis
- 11.5. Novartis AG
- 11.5.1. Business Overview
- 11.5.2. Financial Analysis
- 11.5.3. Product Portfolio
- 11.5.4. Recent Development and Strategies Adopted
- 11.5.5. SWOT Analysis
- 11.6. Pfizer Inc
- 11.6.1. Business Overview
- 11.6.2. Financial Analysis
- 11.6.3. Product Portfolio
- 11.6.4. Recent Development and Strategies Adopted
- 11.6.5. SWOT Analysis
- 11.7. Reckitt Benckiser Group Plc
- 11.7.1. Business Overview
- 11.7.2. Financial Analysis
- 11.7.3. Product Portfolio
- 11.7.4. Recent Development and Strategies Adopted
- 11.7.5. SWOT Analysis
- 11.8. Sanofi
- 11.8.1. Business Overview
- 11.8.2. Financial Analysis
- 11.8.3. Product Portfolio
- 11.8.4. Recent Development and Strategies Adopted
- 11.8.5. SWOT Analysis
- 11.9. Sun Pharmaceutical Industries Ltd.
- 11.9.1. Business Overview
- 11.9.2. Financial Analysis
- 11.9.3. Product Portfolio
- 11.9.4. Recent Development and Strategies Adopted
- 11.9.5. SWOT Analysis
- 11.10. Topical Biomedics, Inc.
- 11.10.1. Business Overview
- 11.10.2. Financial Analysis
- 11.10.3. Product Portfolio
- 11.9.4. Recent Development and Strategies Adopted
- 11.9.5. SWOT Analysis
- Chapter 12. Key Takeaways
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook